Ampio Announces Voluntary Delisting and SEC Deregistration

ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”) today announced that its Board of Directors determined to voluntarily delist its common stock from the NYSE American and deregister its common stock in order to…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks